149 related articles for article (PubMed ID: 9163300)
1. Hypolipidemic drugs in coronary artery disease.
Bittar GB
Ann Intern Med; 1997 Jun; 126(11):916-7. PubMed ID: 9163300
[No Abstract] [Full Text] [Related]
2. Hypolipidemic drugs in coronary artery disease.
Isley WL
Ann Intern Med; 1997 Jun; 126(11):916; author reply 917. PubMed ID: 9163299
[No Abstract] [Full Text] [Related]
3. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
4. Statin trials and goals of cholesterol-lowering therapy.
Grundy SM
Circulation; 1998 Apr; 97(15):1436-9. PubMed ID: 9576422
[No Abstract] [Full Text] [Related]
5. Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levels.
Havel RJ
Circulation; 1997 Oct; 96(7):2113-4. PubMed ID: 9337175
[No Abstract] [Full Text] [Related]
6. Lipid lowering in high-risk populations: how low should we go?
Watson K
Ethn Dis; 2001; 11(4):834-7. PubMed ID: 11763308
[No Abstract] [Full Text] [Related]
7. Beyond statins: what to expect from add-on lipid regulating therapy?
Laufs U; Weintraub WS; Packard CJ
Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
[No Abstract] [Full Text] [Related]
8. Implications of 4S evidence on baseline lipid levels.
Jacobson TA
Lancet; 1995 Jul; 346(8968):181-2. PubMed ID: 7603245
[No Abstract] [Full Text] [Related]
9. A symposium: lipid management summit on improving practice outcome. Introduction.
Ballantyne CM
Am J Cardiol; 2000 Feb; 85(3A):1A-2A. PubMed ID: 10695700
[No Abstract] [Full Text] [Related]
10. [The role of lipid metabolism in the prevention of coronary heart disease].
Mathes P; Thiery J
Z Kardiol; 2005; 94 Suppl 3():III/43-55. PubMed ID: 16258792
[TBL] [Abstract][Full Text] [Related]
11. Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias.
Hecht HS
Am J Cardiol; 2001 Aug; 88(4):406-8. PubMed ID: 11545763
[No Abstract] [Full Text] [Related]
12. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
März W
MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
[TBL] [Abstract][Full Text] [Related]
13. [Hypolipidemic agents and their indication].
Teramoto T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
[No Abstract] [Full Text] [Related]
14. Lipid analysis in an aging population.
Pallazola VA; Sathiyakumar V; Martin SS
Aging (Albany NY); 2019 Feb; 11(4):1073-1074. PubMed ID: 30733425
[No Abstract] [Full Text] [Related]
15. Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an educational program on dyslipidemia treatment.
Ghosh S; Aronow WS
J Gerontol A Biol Sci Med Sci; 2003 May; 58(5):M432-5. PubMed ID: 12730252
[TBL] [Abstract][Full Text] [Related]
16. Intensive drug therapy of hypercholesterolemia.
Witztum JL
Am Heart J; 1987 Feb; 113(2 Pt 2):603-9. PubMed ID: 3544777
[No Abstract] [Full Text] [Related]
17. Implications of 4S evidence on baseline lipid levels.
Durrington PN
Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
[No Abstract] [Full Text] [Related]
18. Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins.
Pearson TA
Am J Cardiol; 1998 Nov; 82(10A):28S-30S. PubMed ID: 9860353
[No Abstract] [Full Text] [Related]
19. Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy.
Kopjar B; Sales AE; Piñeros SL; Sun H; Li YF; Hedeen AN
Am J Cardiol; 2003 Jun; 91(11):1352-4. PubMed ID: 12767433
[No Abstract] [Full Text] [Related]
20. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
